Close Menu

executive appointment

Former Dionex President and CEO Frank Witney will take over at Affymetrix on July 1.

The funds will be used to further develop its product pipeline and discover novel biomarkers for cardiovascular diseases.

In addition to being on the board, Bruce Huebner is expected to lead a special committee to evaluate the current sales and marketing strategy of Vermillion's OVA1 test.

The firm appointed the former COO of Ventana Medical Systems to lead the molecular diagnostics firm.

Nagarkatti spent his entire career at Sigma-Aldrich and rose to the post of CEO in 2006.

The Broad Institute has taken out advertisements seeking to hire a chief development officer whose responsibilities include the ability to "create and manage a caseload of prospects with the capacity to make gifts at the level of $5 million plus."

People In The News

A few startups disclosed their executive teams, while Caris named two new managers in Europe, and DNA Genotek appointed a new CFO.

As the firm completes the first phase of its restructuring, it reported a 51 percent increase in revenues and appointed a new CEO.

The firm said that it saw particularly strong growth for its reagent test revenues as it reported its first quarterly results as a publicly traded company in the US.

The institute's deputy director since 2007, Stratton is a team leader of Sanger's Cancer Genome Project, and a leader of the International Cancer Gene Consortium. He succeeds Allan Bradley, who in March stepped down after 10 years at the institute's helm.


Elsevier and a Norwegian consortium come to a "read-and-publish" agreement, according to Nature News.

Researchers in France have explored the genetic history of the blue cheese mold, Forbes reports.

The South China Morning Post reports eight genetic testing firms in Hong Kong are under scrutiny for potentially misleading consumers.

In Science this week: platform to diagnose genetic disease in children, lung disease-causing genetic mutation corrected in mice, and more.